Calcium-activated-calcineurin reduces the In vitro and In vivo sensitivity of fluconazole to Candida albicans via Rta2p.
Calcium-activated-calcineurin reduces the In vitro and In vivo sensitivity of fluconazole to Candida albicans via Rta2p.
复制标题
DOI:
10.1371/journal.pone.0048369
复制
发表时间:
2012
期刊:
影响因子:
3.7
通讯作者:
Jiang YY
中科院分区:
文献类型:
--
作者:
Jia Y;Tang RJ;Wang L;Zhang X;Wang Y;Jia XM;Jiang YY
Due to the emergence of drug-resistance, first-line therapy with fluconazole (FLC) increasingly resulted in clinical failure for the treatment of candidemia. Our previous studies found that in vitro RTA2 was involved in the calcineurin-mediated resistance to FLC in C. albicans. In this study, we found that calcium-activated-calcineurin significantly reduced the in vitro sensitivity of C. albicans to FLC by blocking the impairment of FLC to the plasma membrane via Rta2p. Furthermore, we found that RTA2 itself was not involved in C. albicans virulence, but the disruption of RTA2 dramatically increased the therapeutic efficacy of FLC in a murine model of systemic candidiasis. Conversely, both re-introduction of one RTA2 allele and ectopic expression of RTA2 significantly reduced FLC efficacy in a mammalian host. Finally, we found that calcium-activated-calcineurin, through its target Rta2p, dramatically reduced the efficacy of FLC against candidemia. Given the critical roles of Rta2p in controlling the efficacy of FLC, Rta2p can be a potential drug target for antifungal therapies.
登录
查看更多内容
影响因子:
11.8
作者:
Horn, David L.;Neofytos, Dionissios;Webster, Karen M.
通讯作者:
Webster, Karen M.
影响因子:
4.9
作者:
Gamarra, Soledad;Rocha, Elousa Maria F.;Perlin, David S.
通讯作者:
Perlin, David S.
影响因子:
6.7
作者:
Cowen LE
通讯作者:
Cowen LE
影响因子:
6.7
作者:
Epp E;Vanier G;Harcus D;Lee AY;Jansen G;Hallett M;Sheppard DC;Thomas DY;Munro CA;Mullick A;Whiteway M
通讯作者:
Whiteway M
影响因子:
4.8
作者:
Gaigg, B;Timischl, B;Schneiter, R
通讯作者:
Schneiter, R